SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-21-004520
Filing Date
2021-04-20
Accepted
2021-04-20 17:02:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20210420xdefa14a.htm DEFA14A 32950
2 GRAPHIC tmb-20210420xdefa14a002.jpg GRAPHIC 147702
3 GRAPHIC tmb-20210420xdefa14a001.jpg GRAPHIC 171461
  Complete submission text file 0001558370-21-004520.txt   473722
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37719 | Film No.: 21838641
SIC: 2834 Pharmaceutical Preparations